TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance9
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Middle East & Africa T Cell Therapy Market, by Country (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa T Cell Therapy Market Landscape
4.1 Overview
5. Middle East & Africa T Cell Therapy Market - Key Industry Dynamics
5.1 Market Drivers:
5.1.1 Growing Burden of Cancer Worldwide
5.1.2 Increasing Number of T-Cell Therapy Approvals
5.2 Market Restraints
5.2.1 Side-effects of CAR T-Cell Therapy
5.3 Market Opportunities
5.3.1 Growing Investment in T-Cell Therapy
5.4 Future Trends
5.4.1 Rising Number of CAR T-Cell Therapies in Clinical Trials
5.5 Impact Analysis:
6. T Cell Therapy Market - Middle East & Africa Market Analysis
6.1 Middle East & Africa T Cell Therapy Market Revenue (US$ Mn), 2022 - 2030
7. Middle East & Africa T Cell Therapy Market - Revenue and Forecast to 2030 - by Modality
7.1 Overview
7.2 Middle East & Africa T Cell Therapy Market Revenue Share, by Modality, 2022 & 2030 (%)
7.3 Research
7.3.1 Overview
7.3.2 Research: Middle East & Africa T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Commercialized
7.4.1 Overview
7.4.2 Commercialized: Middle East & Africa T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa T Cell Therapy Market - Revenue and Forecast to 2030 - by Therapy Type
8.1 Overview
8.2 Middle East & Africa T Cell Therapy Market Revenue Share, by Therapy Type 2022 & 2030 (%)
8.3 CAR T-cell Therapy
8.3.1 Overview
8.3.2 CAR T-cell Therapy: Middle East & Africa T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 T-cell Receptor (TCR)-based.
8.4.1 Overview
8.4.2 T-cell Receptor (TCR)-based: Middle East & Africa T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa T Cell Therapy Market - Revenue and Forecast to 2030 - by Indication
9.1 Overview
9.2 Middle East & Africa T Cell Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)
9.3 Hematologic Malignancies
9.3.1 Overview
9.3.2 Hematologic Malignancies: Middle East & Africa T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3.3 Middle East & Africa T Cell Therapy Market, by Haematological Malignancies, 2020-2030 (US$ Million)
9.4 Solid Tumor
9.4.1 Overview
9.4.2 Solid Tumor: Middle East & Africa T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa T Cell Therapy Market - Country Analysis
10.1 Overview
10.1.1.1 Middle East & Africa T Cell Therapy Market, by Country
10.1.1.2 Saudi Arabia
10.1.1.2.1 Saudi Arabia: Middle East & Africa T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.2 Saudi Arabia: Middle East & Africa T Cell Therapy Market, by Modality, 2020-2030 (US$ Million)
10.1.1.2.3 Saudi Arabia: Middle East & Africa T Cell Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.1.1.2.4 Saudi Arabia: Middle East & Africa T Cell Therapy Market, by Indication, 2020-2030 (US$ Million)
10.1.1.2.4.1 Saudi Arabia: Middle East & Africa T Cell Therapy Market, For Hematologic Malignancies by Indication, 2020-2030 (US$ Million)
10.1.1.3 Israel
10.1.1.3.1 Israel: Middle East & Africa T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.2 Israel: Middle East & Africa T Cell Therapy Market, by Modality, 2020-2030 (US$ Million)
10.1.1.3.3 Israel: Middle East & Africa T Cell Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.1.1.3.4 Israel: Middle East & Africa T Cell Therapy Market, by Indication, 2020-2030 (US$ Million)
10.1.1.3.4.1 Israel: Middle East & Africa T Cell Therapy Market, For Hematologic Malignancies by Indication, 2020-2030 (US$ Million)
10.1.1.4 Rest of Middle East & Africa
10.1.1.4.1 Rest of Middle East & Africa: Middle East & Africa T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa T Cell Therapy Market, by Modality, 2020-2030 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa T Cell Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Middle East & Africa T Cell Therapy Market, by Indication, 2020-2030 (US$ Million)
10.1.1.4.4.1 Rest of Middle East & Africa: Middle East & Africa T Cell Therapy Market, For Hematologic Malignancies by Indication, 2020-2030 (US$ Million)
11. T Cell Therapy Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in T Cell Therapy Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Legend Biotech Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Janssen Global Services LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Gilead Sciences Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bristol-Myers Squibb Co
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Novartis AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms



List of Tables
Table 1. Middle East & Africa T Cell Therapy Market Segmentation
Table 2. Middle East & Africa T Cell Therapy Market, by Hematological Malignancies - Revenue and Forecast to 2030 (US$ Million)
Table 3. Saudi Arabia: Middle East & Africa T Cell Therapy Market, by Modality - Revenue and Forecast to 2030 (US$ Million)
Table 4. Saudi Arabia: Middle East & Africa T Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia: Middle East & Africa T Cell Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 6. Saudi Arabia: Middle East & Africa T Cell Therapy Market, For Hematologic Malignancies by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 7. Israel: Middle East & Africa T Cell Therapy Market, by Modality - Revenue and Forecast to 2030 (US$ Million)
Table 8. Israel: Middle East & Africa T Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 9. Israel: Middle East & Africa T Cell Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 10. Israel: Middle East & Africa T Cell Therapy Market, For Hematologic Malignancies by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 11. Rest of Middle East & Africa: Middle East & Africa T Cell Therapy Market, by Modality - Revenue and Forecast to 2030 (US$ Million)
Table 12. Rest of Middle East & Africa: Middle East & Africa T Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. Rest of Middle East & Africa: Middle East & Africa T Cell Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of Middle East & Africa: Middle East & Africa T Cell Therapy Market, For Hematologic Malignancies by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 15. Recent Organic Growth Strategies in T Cell Therapy Market
Table 16. Recent Inorganic Growth Strategies in the T Cell Therapy Market
Table 17. Glossary of Terms, Middle East & Africa T Cell Therapy Market

List of Figures
Figure 1. Middle East & Africa T Cell Therapy Market Segmentation, By Country
Figure 2. Middle East & Africa T Cell Therapy Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa T Cell Therapy Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Middle East & Africa T Cell Therapy Market Revenue Share, by Modality, 2022 & 2030 (%)
Figure 6. Research: Middle East & Africa T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Commercialized: Middle East & Africa T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Middle East & Africa T Cell Therapy Market Revenue Share, by Therapy Type 2022 & 2030 (%)
Figure 9. CAR T-cell Therapy: Middle East & Africa T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. T-cell Receptor (TCR)-based: Middle East & Africa T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Middle East & Africa T Cell Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)
Figure 12. Hematologic Malignancies: Middle East & Africa T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Solid Tumor: Middle East & Africa T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Middle East & Africa T Cell Therapy Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 15. Middle East & Africa T Cell Therapy Market, By Key Countries, 2022 and 2030 (%)
Figure 16. Saudi Arabia: Middle East & Africa T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 17. Israel: Middle East & Africa T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 18. Rest of Middle East & Africa: Middle East & Africa T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 19. Growth Strategies in T Cell Therapy Market

CONTACT US

If you have any queries about this report or would like further information, please contact us:

US: +1-646-491-9876
Asia-Pacific: +91-20-69018686
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com




DISCLAIMER

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, \"The Insight Partners\".